Tag Archives: ANVISA

Battle of the feds: end of the conflict between INPI and ANVISA on the registration of pharmaceutical product Patents

After 15 years, the feds have finally decided to unlock the system. In order to address certain amendments and add-ons to Law No. 9,276/96, the so-called Intellectual Property Law, in 2001 Brazil’s National Congress promulgated Federal Law No. 10,196. Despite appointing several technical and procedural parameters related to the National Industrial Property Institute (INPI), this … Continue Reading

New Brazil’s ANVISA Rules Expand Facilities for Investors in Life Sciences

On August 25, 2016, Brazil’s National Health Surveillance Agency (“ANVISA”) granted a new resolution (“RDC”) to improve a bordering field of the product registration process. This new procedure aims to address reported problems concerning red tape slow process of ownership transfer of registered products before Health Surveillance Agencies.… Continue Reading
LexBlog